Teva Pharmaceutical Industries (TEVA) Goodwill & Intangibles (2016 - 2025)
Historic Goodwill & Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $19.8 billion.
- Teva Pharmaceutical Industries' Goodwill & Intangibles rose 110.4% to $19.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.8 billion, marking a year-over-year increase of 110.4%. This contributed to the annual value of $19.8 billion for FY2025, which is 110.4% up from last year.
- According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Goodwill & Intangibles is $19.8 billion, which was up 110.4% from $19.9 billion recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Goodwill & Intangibles ranged from a high of $28.7 billion in Q1 2021 and a low of $7.2 billion during Q2 2022
- Moreover, its 5-year median value for Goodwill & Intangibles was $22.5 billion (2023), whereas its average is $22.4 billion.
- Its Goodwill & Intangibles has fluctuated over the past 5 years, first crashed by 7484.67% in 2022, then surged by 21837.3% in 2023.
- Over the past 5 years, Teva Pharmaceutical Industries' Goodwill & Intangibles (Quarter) stood at $25.1 billion in 2021, then dropped by 6.58% to $23.4 billion in 2022, then decreased by 3.77% to $22.6 billion in 2023, then fell by 13.29% to $19.6 billion in 2024, then grew by 1.1% to $19.8 billion in 2025.
- Its Goodwill & Intangibles stands at $19.8 billion for Q4 2025, versus $19.9 billion for Q3 2025 and $20.1 billion for Q2 2025.